Connective Capital Management, LLC Poly Pid Ltd. Transaction History

Connective Capital Management, LLC

  • $110 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

May 16, 2024
SELL
$0.34 - $0.45 $8,255 - $10,926
-24,281 Closed
0 $0
Q1 2023

May 16, 2024
BUY
$0.4 - $1.08 $9,712 - $26,223
24,281 New
24,281 $11.2 Million

About PolyPid Ltd.

PYPD Quotes by TradingView
  • Ticker PYPD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,551,200
  • Market Cap $61.6M
  • Description
  • PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...
More about PYPD
Track This Portfolio

Track Connective Capital Management, LLC Portfolio

Follow Connective Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connective Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Connective Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email